Monetary Management Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.77M Sell
13,171
-125
-0.9% -$42.8K 0.98% 22
2026
Q1
$4.68M Buy
13,296
+25
+0.2% +$8.91K 1.12% 16
2025
Q4
$4.34M Sell
13,271
-600
-4% -$190K 1% 18
2025
Q3
$3.91M Sell
13,871
-225
-2% -$65.3K 0.9% 19
2025
Q2
$3.94M Buy
14,096
+25
+0.2% +$7.08K 0.97% 19
2025
Q1
$4.38M Buy
14,071
+50
+0.4% +$14.8K 1.18% 14
2024
Q4
$3.65M Buy
14,021
+175
+1% +$51.9K 0.95% 20
2024
Q3
$4.46M Sell
13,846
-400
-3% -$131K 1.15% 15
2024
Q2
$4.45M Sell
14,246
-350
-2% -$103K 1.18% 16
2024
Q1
$4.15M Buy
14,596
+310
+2% +$90.7K 1.16% 15
2023
Q4
$4.11M Sell
14,286
-600
-4% -$163K 1.28% 14
2023
Q3
$4M Buy
14,886
+125
+0.8% +$31.2K 1.33% 14
2023
Q2
$3.28M Sell
14,761
-1,870
-11% -$434K 1% 21
2023
Q1
$4.02M Sell
16,631
-25
-0.2% -$6.14K 1.18% 14
2022
Q4
$4.37M Buy
16,656
+175
+1% +$46.9K 1.37% 11
2022
Q3
$3.71M Sell
16,481
-50
-0.3% -$12.1K 1.22% 14
2022
Q2
$4.02M Buy
16,531
+100
+0.6% +$24.5K 1.26% 16
2022
Q1
$3.97M Sell
16,431
-410
-2% -$94.2K 1.05% 23
2021
Q4
$3.79M Sell
16,841
-1,305
-7% -$275K 0.94% 29
2021
Q3
$3.86M Buy
18,146
+2,375
+15% +$547K 1.06% 25
2021
Q2
$3.84M Buy
15,771
+25
+0.2% +$6.15K 1.16% 20
2021
Q1
$3.92M Buy
15,746
+100
+0.6% +$23.9K 1.23% 15
2020
Q4
$3.6M Buy
15,646
+300
+2% +$69.2K 1.19% 19
2020
Q3
$3.9M Sell
15,346
-773
-5% -$192K 1.39% 15
2020
Q2
$3.8M Sell
16,119
-1,325
-8% -$302K 1.44% 12
2020
Q1
$3.54M Buy
17,444
+825
+5% +$180K 1.56% 13
2019
Q4
$4.01M Sell
16,619
-899
-5% -$198K 1.46% 13
2019
Q3
$3.39M Buy
17,518
+325
+2% +$62.4K 1.28% 18
2019
Q2
$3.17M Hold
17,193
1.22% 19
2019
Q1
$3.27M Sell
17,193
-2,785
-14% -$532K 1.29% 19
2018
Q4
$3.89M Sell
19,978
-2,930
-13% -$572K 1.76% 11
2018
Q3
$4.75M Sell
22,908
-150
-0.7% -$29.6K 1.81% 12
2018
Q2
$4.26M Sell
23,058
-360
-2% -$63.7K 1.74% 14
2018
Q1
$3.99M Sell
23,418
-960
-4% -$176K 1.65% 16
2017
Q4
$4.24M Buy
24,378
+460
+2% +$81.4K 1.71% 13
2017
Q3
$4.46M Buy
23,918
+995
+4% +$176K 1.88% 11
2017
Q2
$3.95M Buy
22,923
+220
+1% +$35.8K 1.61% 15
2017
Q1
$3.73M Buy
22,703
+300
+1% +$49.8K 1.62% 13
2016
Q4
$3.28M Buy
22,403
+5,190
+30% +$781K 1.51% 16
2016
Q3
$2.87M Sell
17,213
-375
-2% -$63.4K 1.33% 24
2016
Q2
$2.68M Hold
17,588
1.24% 26
2016
Q1
$2.64M Sell
17,588
-8,085
-31% -$1.2M 1.28% 22
2015
Q4
$4.17M Buy
25,673
+390
+2% +$61.3K 2% 5
2015
Q3
$3.5M Buy
25,283
+275
+1% +$43.3K 1.75% 8
2015
Q2
$3.84M Buy
25,008
+300
+1% +$48.1K 1.73% 10
2015
Q1
$3.95M Buy
24,708
+4,095
+20% +$645K 1.74% 7
2014
Q4
$3.28M Sell
20,613
-275
-1% -$42.9K 1.46% 15
2014
Q3
$2.93M Buy
20,888
+1,000
+5% +$131K 1.36% 18
2014
Q2
$2.35M Buy
19,888
+1,525
+8% +$177K 1.1% 28
2014
Q1
$2.27M Buy
18,363
+3,575
+24% +$434K 1.05% 35
2013
Q4
$1.69M Hold
14,788
0.78% 48
2013
Q3
$1.66M Buy
14,788
+375
+3% +$40.7K 0.87% 49
2013
Q2
$1.42M Buy
+14,413
New +$1.5M 0.78% 48

Other funds holding AMGN

Monetary Management Group's AMGN Position: Q2 2026 in Review

Monetary Management Group reduced its Amgen (AMGN) stake by 0.94% in Q2 2026, selling an estimated $42.8K and leaving 13,171 shares worth $4.77M. The position accounts for 0.98% of the portfolio, ranked #22.

Monetary Management Group first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Monetary Management Group held 13,171 shares of Amgen worth $4.77M as of Q2 2026.
  • Monetary Management Group sold 125 Amgen shares in Q2 2026, an estimated $42.8K.
  • Amgen made up 0.98% of Monetary Management Group's portfolio in Q2 2026, its #22 holding.
  • Monetary Management Group first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Monetary Management Group's 13F filing for Q2 2026, filed 12 Aug 2026.